Chlorbenzoxamine

{{Short description|Chemical compound}}

{{context|date=May 2014}}

{{Drugbox

| IUPAC_name = 1-(2-[(2-chlorophenyl)(phenyl)methoxy]ethyl)-4-(2-methylbenzyl)piperazine

| image = Chlorbenzoxamine.png

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 522-18-9

| ATC_prefix = A03

| ATC_suffix = AX03

| PubChem = 71636

| DrugBank =

| ChEMBL = 2110781

| ChemSpiderID = 64700

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = N52918SLYN

| KEGG = D07093

| C=27 | H=31 | Cl=1 | N=2 | O=1

| smiles = Clc1ccccc1C(OCCN2CCN(CC2)Cc3ccccc3C)c4ccccc4

}}

Chlorbenzoxamine is a drug used for functional gastrointestinal disorders.